Vaccinations in CLL: implications for COVID-19

por Shadman, Mazyar, Ujjani, Chaitra
Publicado no Blood (2021)

Improving Outcomes for Patients With Chronic Lymphocytic Leukemia

por Shadman, Mazyar, Goodrich, Amy
Publicado no J Adv Pract Oncol (2020)

Hematopoietic Cell Transplantation for Older Patients with MDS

por Shadman, Mazyar, Deeg, H. Joachim
Publicado em 2014

Childhood trauma fatality and resource allocation in injury control programs in a developing country

por Roudsari, Bahman S, Shadman, Mazyar, Ghodsi, Mohammad
Publicado em 2006

Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma

por Chow, Victor A., Shadman, Mazyar, Gopal, Ajay K.
Publicado no Blood (2018)

Associations between Allergies and Risk of Hematologic Malignancies: Results from the VITamins and Lifestyle (VITAL) Cohort Study

por Shadman, Mazyar, White, Emily, De Roos, Anneclaire J., Walter, Roland B.
Publicado em 2013

Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient

por Hill, Joshua A., Ujjani, Chaitra S., Greninger, Alexander L., Shadman, Mazyar, Gopal, Ajay K.
Publicado no Cancer Cell (2021)

Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk

por Shadman, Mazyar, Newcomb, Polly A, Hampton, John M, Wernli, Karen J, Trentham-Dietz, Amy
Publicado em 2009

BTK inhibitors in cancer patients with COVID19: “The winner will be the one who controls that chaos” (Napoleon Bonaparte)

por Chong, Elise A., Roeker, Lindsey E., Shadman, Mazyar, Davids, Matthew S., Schuster, Stephen J., Mato, Anthony R.
Publicado no Clin Cancer Res (2020)

Allogeneic Hematopoietic Cell Transplant for Patients with End Stage Renal Disease Requiring Dialysis – a Single Institution Experience

por Shadman, Mazyar, Hingorani, Sangeeta, Lanum, Scott A., Pagel, John M., Storb, Rainer, Maloney, David G., Sandmaier, Brenda M.
Publicado no Leuk Lymphoma (2016)

Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy

por Chow, Victor A., Gopal, Ajay K., Gauthier, Jordan, Tseng, Yolanda D., Turtle, Cameron J., Maloney, David G., Shadman, Mazyar
Publicado no Blood Adv (2020)

Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms

por Burnett-Hartman, Andrea N., Newcomb, Polly A., Mandelson, Margaret T., Adams, Scott V., Wernli, Karen J., Shadman, Mazyar, Wurscher, Michelle A., Makar, Karen W.
Publicado em 2011

Radioimmunotherapy Consolidation using (131)I-Tositumomab for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission

por Shadman, Mazyar, Gopal, Ajay K., Kammerer, Britt, Becker, Pamela S., Maloney, David G., Pender, Barbara, Shustov, Andrei R., Press, Oliver W., Pagel, John M.
Publicado no Leuk Lymphoma (2015)

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

por Rossi, Davide, Shadman, Mazyar, Condoluci, Adalgisa, Brown, Jennifer R., Byrd, John C., Gaidano, Gianluca, Hallek, Michael, Hillmen, Peter, Mato, Anthony, Montserrat, Emili, Ghia, Paolo
Publicado no Hemasphere (2020)

Management of CLL patients early in the COVID‐19 pandemic: An international survey of CLL experts

por Koffman, Brian, Mato, Anthony, Byrd, John C., Danilov, Alexey, Hedrick, Brad, Ujjani, Chaitra, Roeker, Lindsey, Stephens, Deborah M., Davids, Matthew S., Pagel, John M., Shadman, Mazyar
Publicado no Am J Hematol (2020)

Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps

por Wernli, Karen J., Newcomb, Polly A., Wang, Yinghui, Makar, Karen W., Shadman, Mazyar, Chia, Victoria M., Burnett-Hartman, Andrea, Wurscher, Michelle A., Zheng, Yingye, Mandelson, Margaret T.
Publicado em 2010

Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

por Shadman, Mazyar, Mawad, Raya, Dean, Carol, Chen, Tara, Shannon-Dorcy, Kathleen, Sandhu, Vicky, Hendrie, Paul C., Scott, Bart L., Walter, Roland B., Becker, Pamela S., Pagel, John, Estey, Elihu H.
Publicado no Am J Hematol (2015)

In vivo Localization of (90)Y- and (177)Lu-Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model

por Balkin, Ethan R., Kenoyer, Aimee, Orozco, Johnnie J., Hernandez, Alexandra, Shadman, Mazyar, Fisher, Darrell R., Green, Damian J., Hylarides, Mark D., Press, Oliver W., Wilbur, D. Scott, Pagel, John M.
Publicado em 2014

Sequential phase II Southwest Oncology Group studies (S0012 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with cyclosporine, in older patients with...

por Chauncey, Thomas R., Gundacker, Holly, Shadman, Mazyar, List, Alan F., Dakhil, Shaker R., Erba, Harry P., Slovak, Marilyn L., Chen, I-Ming, Willman, Cheryl L., Kopecky, Kenneth J., Appelbaum, Frederick R.
Publicado em 2009

Anti-CD45 Radioimmunotherapy with (90)Y but Not (177)Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model

por Orozco, Johnnie J., Balkin, Ethan R., Gooley, Ted A., Kenoyer, Aimee, Hamlin, Donald K., Wilbur, D. Scott, Fisher, Darrell R., Hylarides, Mark D., Shadman, Mazyar, Green, Damian J., Gopal, Ajay K., Press, Oliver W., Pagel, John M.
Publicado no PLoS One (2014)